How much of a health app should my team build from scratch?

For digital health founders and product managers, the pressure to balance innovation with execution is immense. The decision of what to build, what to license, and how to allocate scarce engineering resources is one of the most consequential choices a leadership team can make. While the idea of a completely custom-built platform is appealing, the strategic and financial calculus behind the 'health app build from scratch vs buy' debate is rarely straightforward. This decision influences not just the initial product launch but also long-term scalability, regulatory exposure, and the company's ability to compete.

"A 2023 analysis from researchers at Penn LDI noted that while building custom solutions can offer a unique competitive advantage, the path is often fraught with 'hidden costs and higher stakes' due to healthcare's unique complexities, including HIPAA compliance and interoperability standards."

The build vs. buy decision framework for health apps

The core question for any digital health team is not just about initial cost, but about total cost of ownership and strategic focus. A health app build from scratch vs buy analysis must weigh the desire for a perfectly tailored solution against the realities of time to market, resource allocation, and ongoing maintenance. Building from the ground up provides maximum control but consumes a company's most valuable resources: time and engineering talent. It transforms the company into a software development organization, which may distract from its core clinical or wellness mission. Buying or licensing, on the other hand, accelerates the timeline and provides cost predictability, but requires a trade-off in terms of customization and control. This decision is not merely technical; it is a fundamental business strategy choice that defines the company's operational focus and competitive posture.

Feature	Build From Scratch	Buy/License (White-Label)
Initial Cost	High ($100k - $500k+)	Low to Moderate (Licensing fees)
Speed to Market	Slow (9-18+ months)	Fast (1-3 months)
Customization	Unlimited	High (Branding), Limited (Core)
Resource Allocation	Heavy (Dedicated dev, QA, DevOps)	Light (Integration, vendor mgmt)
Maintenance Burden	Full responsibility (updates, security)	Shared / Vendor responsibility
Regulatory Risk	Full ownership of compliance	Vendor shares compliance burden
Strategic Focus	Becomes a software company	Focus on core business/clinical

The case for building from scratch

Building a health application from the ground up is often the default consideration for well-funded startups aiming for deep technological differentiation. The primary advantages lie in control and specificity.

• Total Control: Every line of code, every feature, and every user workflow can be tailored to the company's exact vision.
• Intellectual Property: A custom build results in proprietary IP that can become a core asset and a competitive differentiator.
• Unique Workflows: For companies with a truly novel clinical or user engagement model, off-the-shelf solutions may not be flexible enough.

However, this path is resource-intensive. A 2023 report on software development costs indicates that a moderately complex, HIPAA-compliant health app can easily exceed $250,000 in initial development costs, not including ongoing maintenance, which can be 15-20% of the initial build cost per year.

The case for licensing a platform

Licensing a white-label or platform solution has become an increasingly popular strategy, allowing companies to focus their resources on their unique value proposition rather than on building commodity infrastructure.

• Speed: The most significant advantage is speed to market. A white-label platform can often be branded and deployed in weeks or months, not years.
• Cost Predictability: Licensing models typically involve predictable subscription or per-user fees, reducing financial uncertainty.
• Core Competence: By outsourcing the underlying technology, a company can focus on its clinical expertise, distribution strategy, and user acquisition.
• Regulatory Leverage: Reputable platform vendors have already navigated complex compliance landscapes like HIPAA and SOC 2, de-risking the project for their clients.

Industry Applications

Telehealth and virtual care startups

For startups in the telehealth space, the core challenge is often user and provider acquisition. Speed is critical. As such, many opt to license a platform for core functionality like video, scheduling, and even remote vitals monitoring, while they focus on building a brand and a provider network. The decision to bring technology in-house often happens at a later stage of maturity.

Hospital and health system innovation

Hospital IT teams are traditionally risk-averse. When launching patient-facing applications or remote monitoring programs, they prioritize solutions that are already HIPAA-compliant, secure, and can integrate with existing EHR systems. A study by Medaptus in 2022 highlighted that for hospitals, the 'buy' decision is often driven by the need for proven security and the high cost and complexity of navigating internal compliance reviews for new software built from scratch.

Employer wellness platforms

Companies in the corporate wellness space live and die by engagement. They need to launch branded, user-friendly applications quickly to fulfill corporate contracts. The underlying technology for activity tracking or health screenings is often a commodity; the value is in the program design and branding. This makes white-label solutions a natural fit.

Current research and evidence

The academic and industry consensus points toward a hybrid approach becoming the dominant model. Research from organizations like Forbes and Penn LDI consistently highlights that the most successful digital health companies are those that strategically blend licensed technology with a small, highly differentiated set of custom-built features. A 2023 industry analysis pointed out that the average timeline to build, test, and deploy a market-ready health app from scratch is approximately 14 months, a timeline that few early-stage startups can afford. By licensing a foundational platform, that timeline can be drastically reduced, allowing the company to begin generating data and revenue sooner. This "buy-and-build" strategy allows a company to get to market quickly on a proven foundation and then invest its engineering resources in creating a unique "top layer" that defines its competitive edge.

The future of health app development

The future of digital health infrastructure appears to be moving away from monolithic, "build-everything" approaches and toward a more modular, platform-based ecosystem. We are seeing a rise in OEM (Original Equipment Manufacturer) and platform licensing models where specialized companies provide the "engine" for functions like contactless vitals measurement, data analysis, or patient communication. This allows app developers to assemble a best-of-breed solution without having to become experts in every underlying technology. This trend suggests that the 'health app build from scratch vs buy' decision will become even more nuanced, focusing on identifying the 10-20% of the application that is truly a core differentiator and licensing the rest.

Frequently asked questions

What is the average cost to build a health app from scratch? While a simple app might start around $60,000, a moderately complex, HIPAA-compliant app with features like EHR integration, custom dashboards, and data analytics typically ranges from $150,000 to over $400,000 for the initial build.

How long does it take to develop a health app in-house? The timeline varies with complexity, but most estimates place the development of a market-ready health app between 9 and 18 months. This includes discovery, design, development, quality assurance, and compliance audits.

Is a hybrid 'build and buy' approach a good strategy? Yes, it is often the most effective strategy. Many successful digital health companies license a core platform to handle commodity features (like user authentication or a data backend) and dedicate their own development resources to building the unique features that differentiate their product in the market.

As the digital health landscape matures, the strategic decision to build or buy is less about a single, one-time choice and more about a continuous evaluation of where a company can create the most value. For teams looking to accelerate their time to market with a proven, scalable, and fully brandable vitals monitoring engine, exploring a platform partnership is a critical strategic step. Circadify is actively addressing this space by providing a white-label platform that allows health companies to launch their own branded applications without the cost and complexity of building from the ground up. To learn more about a custom-build partnership, you can make an inquiry at circadify.com/custom-builds.